e-Article
Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma
Document Type
Article
Author
Source
In: Current Oncology . (Current Oncology, March 2024, 31(3):1543-1555)
Subject
Language
English
ISSN
17187729